Search research articles
Contact Us
Filters
Showing results (121-130 of 148) with videos related to
Page
of 15
Sort By:
Journal of Medicinal Chemistry
|
June 6, 2022
Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein
Lingxin Meng, Jianyang Fang, Liang Zhao, et al.
Theranostics
|
November 8, 2019
Integrin α<sub>v</sub>β<sub>3</sub>-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy
Haojun Chen, Liang Zhao, Kaili Fu, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
May 22, 2025
The reproducibility of [68Ga]Ga-FAPI-04 PET uptake parameters at 15 min and 60 min post-injection
Hongyu Meng, Guixia Pan, Ye Peng, et al.
Theranostics
|
February 16, 2016
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding
Haojun Chen, Guohao Wang, Lixin Lang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 27, 2017
PET-Guided Evaluation and Optimization of Internalized Antibody-Drug Conjugates Targeting Erythropoietin-Producing Hepatoma A2 Receptor
Orit Jacobson, Qing Li, Haojun Chen, et al.
European Radiology
|
August 17, 2022
Comparison of [<sup>68</sup>Ga]Ga-FAPI and [<sup>18</sup>F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study
Haojun Chen, Yizhen Pang, Junpeng Li, et al.
Theranostics
|
December 4, 2024
<sup>68</sup>Ga-FAPI-46 PET/CT in the evaluation of gliomas: comparison with <sup>18</sup>F-FDG PET/CT and contrast-enhanced MRI
Dan Ruan, Jianping Sun, Chengkun Han, et al.
Molecular Pharmaceutics
|
August 2, 2022
Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy
Liang Zhao, Jianhao Chen, Yizhen Pang, et al.
Nuclear Medicine and Biology
|
June 1, 2020
Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma
Xuejun Wen, Changrong Shi, Liang Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 9, 2025
Prognostic value of multiparameter [<sup>68</sup>Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreatic cancer
Zeyu Zhang, Shiwei Guo, Weiwei Su, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 148) with videos related to
Sort By:
Page
of 15
Journal of Medicinal Chemistry
|
June 6, 2022
Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein
Lingxin Meng, Jianyang Fang, Liang Zhao, et al.
Theranostics
|
November 8, 2019
Integrin α<sub>v</sub>β<sub>3</sub>-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy
Haojun Chen, Liang Zhao, Kaili Fu, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
May 22, 2025
The reproducibility of [68Ga]Ga-FAPI-04 PET uptake parameters at 15 min and 60 min post-injection
Hongyu Meng, Guixia Pan, Ye Peng, et al.
Theranostics
|
February 16, 2016
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding
Haojun Chen, Guohao Wang, Lixin Lang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 27, 2017
PET-Guided Evaluation and Optimization of Internalized Antibody-Drug Conjugates Targeting Erythropoietin-Producing Hepatoma A2 Receptor
Orit Jacobson, Qing Li, Haojun Chen, et al.
European Radiology
|
August 17, 2022
Comparison of [<sup>68</sup>Ga]Ga-FAPI and [<sup>18</sup>F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study
Haojun Chen, Yizhen Pang, Junpeng Li, et al.
Theranostics
|
December 4, 2024
<sup>68</sup>Ga-FAPI-46 PET/CT in the evaluation of gliomas: comparison with <sup>18</sup>F-FDG PET/CT and contrast-enhanced MRI
Dan Ruan, Jianping Sun, Chengkun Han, et al.
Molecular Pharmaceutics
|
August 2, 2022
Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy
Liang Zhao, Jianhao Chen, Yizhen Pang, et al.
Nuclear Medicine and Biology
|
June 1, 2020
Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma
Xuejun Wen, Changrong Shi, Liang Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 9, 2025
Prognostic value of multiparameter [<sup>68</sup>Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreatic cancer
Zeyu Zhang, Shiwei Guo, Weiwei Su, et al.
Page
of 15